Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 28 Apr 2023 for aTYR PHARMA INC. Read the official filing
Filing timeline
BuySaleJohn K. Clarke
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John K. Clarke: trading record in brief
All filings by John K. Clarke on record concern aTYR PHARMA Inc, in the capacity of board member. The record holds 2 filings, for trades running from 21 May 2021 to 26 April 2023.
No open-market purchase appears, only 1 sale worth €8,875. Outside the open market, there are 1 option exercise.
The record was last updated on 28 April 2023 with an option exercise in aTYR PHARMA Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John K. Clarke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
6,000 sharesCommon StockSEC:0001209191-23-026069:0
2,500 shares@ US$4.34100.0% of flowCommon StockSEC:0001209191-21-035836:0
2 of 2 declarations
